Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
โ
of holders' portfolios
13F filers
0
institutions
Market cap
$4.0M
2M shares
52-week range
$1.48 โ $96.95
0% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XASE
CS
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.
www.calidibio.comNo one on the platform currently holds CLDI.
No tracked institution reports a position in CLDI as of their last filing.
| Execution date | Ratio |
|---|---|
| 2026-07-31 | 1-for-16reverse |
| 2025-08-05 | 1-for-12reverse |
| 2024-07-15 | 1-for-10reverse |
No one on the platform has traded CLDI yet.
$CLDI expect dilution any day now. No post RS pop, no upcoming catalyst, no volume and no hopeโฆit will continue to fade and they need as much money as possible from the dilutionโฆ:pull the trigger on it already.
View on StockTwits โ$CLDI just waiting on the dilution to startโฆbeen able to accumulate nicely on my short, borrow rate not too bad and will pay off big time as soon as dilution is turned on. No volume, setting up nicely just like after the last reverse split
View on StockTwits โ$CLDI ADDED A VERY GOOD AMOUNT FOR MASSIVE REVERSAL. NANO FLOAT. 52-WEEK LOWEST LEVELS. PURE ACCUMULATION MODE. MULTIBAGGER IMO.
View on StockTwits โ$CLDI exactly like after the last reverse split..:volume dying and price is stagnant. No news expected, once dilution starts with low volume, this will get destroyed! Go look at the chart from the last time
View on StockTwits โ$CLDI better hope for a pop and quick in and out, they will turn on the dilution any day nowโฆover 9 million shares already approved
View on StockTwits โ$CLDI GETTING ACCUMULATED. OVERSOLD ZONE. NANO FLOAT. NEW REVERSE SPLIT GAME. MULTIBAGGER SOON IMO.
View on StockTwits โ$CLDI whoop whoop, was able to grab plenty more shares to short today! Thank you! Drop the dilution Poma @CalidiOfficial
View on StockTwits โ$CLDI bruh, this company is about to dump 9 million shares into the float and will be back under $1 and head back to sub .20
View on StockTwits โ$CLDI is getting ready for massive reversal imo. 52-week lowest levels. Check the website for the info https://www.calidibio.com/
View on StockTwits โRecent $TICKER stream from stocktwits.com โ refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $0 | โ | $-88.32 | $-88.32โ$-88.32 | โ | 1 |
| 2027 | $0 | โ | $-76.80 | $-76.80โ$-76.80 | โ | 1 |
| 2028 | $7M | โ | $-74.88 | $-74.88โ$-74.88 | โ | 1 |
Forward consensus ยท growth is YoY vs the prior fiscal-year estimate ยท Fwd P/E at the current price ยท source: Financial Modeling Prep
Beat consensus in 3 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-03-27 | $-1.56 | $-0.57 | +63.5% |
| 2025-11-11 | $-1.68 | $-2.21 | -31.5% |
| 2025-08-12 | $-1.92 | $-1.99 | -3.6% |
| 2025-05-13 | $-1.80 | $-2.16 | -20.0% |
| 2025-04-04 | $-5.92 | $-4.32 | +27.0% |
| 2024-11-12 | $-10.27 | $-7.80 | +24.0% |
| $21M |
| โ |
| QLGNQualigen Therapeutics, Inc. | $3.21 | +5.59% | $5M | โ |
| SILOSilo Pharma, Inc. | $3.22 | +4.04% | $4M | โ |
Source: Financial Modeling Prep ยท peers by sector/industry